BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

Bridgewest completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer

The newly acquired facility is a cGMP manufacturing plant that produces a wide variety of high quality sterile injectable drug products. The site and ...

April 04, 2023 | News

TATAA Biocenter expands its bioanalytical services with HTG certification

HTG Molecular Diagnostics is a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, HTG EdgeSe...

April 03, 2023 | News

PharmaBlock Expands GMP Project Capacity with New Pennsylvania R&D Facility

Expanding Global Footprint and Enabling the Development of GMP Projects at PharmaBlock USA The new West Chester site covers an area of...

March 28, 2023 | News

Stilla Ruby Chip and naica® system achieve full automation of digital PCR testing for clinical use

Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the industry’s first ‘load-and-go&rsqu...

March 27, 2023 | News

Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and acc...

March 27, 2023 | News

Avirmax CMC Inc. Launches AAV Production with Sf Rhabdovirus-free Cell Lines (Sf-RVF™)

As an insect cell line derived from the ovarian tissue of Spodoptera frugiperda (Sf), the Sf9 cell line in concert with recombinant baculoviruses, has been...

March 23, 2023 | News

Aptamer launches Optimer®-Fc as a new reagent solution for immunohistochemistry

Two top 10 pharma companies are seeking to trial Optimer-Fc for IHC Aptamer is currently working with one of the top three IHC companies to validate the...

March 21, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...

March 20, 2023 | News

Revolutionizing Pharmaceutical Quality Control: The Implementation of Digital Technologies

The pharmaceutical industry is constantly evolving, and new technologies are being introduced to streamline processes and improve quality contr...

March 17, 2023 | News

OGT first to achieve IVDR-certification for FISH probes

OGT, A Sysmex Group Company, announces that IVDR-certification has been granted for eight CytoCell® fluorescence in situ ...

March 13, 2023 | News

Improving Drug Safety and Regulatory Compliance: How AI is Revolutionizing Quality Control in Pharma Manufacturing

Quality control is an essential aspect of pharmaceutical manufacturing that ensures drugs are safe, effective, and meet regulatory standards. However, trad...

March 10, 2023 | Opinion

NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to uni...

March 09, 2023 | News

Estrella Biopharma's ARTEMIS® T Cell Therapy EB103 IND Cleared by FDA for B-Cell Lymphomas Clinical Trial

Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transfo...

March 09, 2023 | News

Stay Connected